Fujifilm to reorganise Medical Systems group companies in Japan
The reorganisation will focus on consolidating functional roles within the group companies to strengthen various aspects, including business…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Jul 23
The reorganisation will focus on consolidating functional roles within the group companies to strengthen various aspects, including business…
19 Jul 23
First multi-centre trial, EXCYTE-1, evaluating the potential of Exscientia’s functional precision medicine platform in solid tumour indication
19 Jul 23
In a Phase 2 study, navacaprant (NMRA-140) monotherapy demonstrated statistically significant and clinically meaningful reductions in symptoms of…
19 Jul 23
New partnership with Niba Labs to offer customized digital PCR (dPCR) assay design services to biopharma customers. Launch…
18 Jul 23
DTx Pharma is engaged in developing small interfering RNA (siRNA) therapeutics for neuroscience indications, leveraging its FALCON platform,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
18 Jul 23
In the trial, acoramidis showed statistically significant improvement in the primary endpoint by a Win Ratio of 1.8…
18 Jul 23
The US health regulator gave its approval after the Antimicrobial Drugs Advisory Committee (AMDAC) unanimously voted in favour…
18 Jul 23
In the trial, donanemab lowered the risk of disease progression and half of the participants who were at…
18 Jul 23
The IND clearance represents a crucial step in the drug's clinical development journey, allowing Adcentrx Therapeutics to move…
18 Jul 23
These recommendations, which have been developed through the Executive Steering Group on Shortages and Safety of Medicinal Products…